Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
UnitedHealth
UNH
|
+$307M |
| 3 |
Global Payments
GPN
|
+$302M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$279M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$433M |
| 2 |
Lam Research
LRCX
|
+$373M |
| 3 |
Pfizer
PFE
|
+$354M |
| 4 |
Verizon
VZ
|
+$341M |
| 5 |
EA
Electronic Arts
EA
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 10.69% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Biohaven
BHVN
$2.17B
| $587K | ﹤0.01% |
+22,575
| New | +$469K |
|
|
PPLI
3277
People Inc
PPLI
$3.02B
| $587K | ﹤0.01% |
14,187
-1,703
| -11% | -$82.6K |
|
3278
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
$1.93B
| $586K | ﹤0.01% |
+27,206
| New | +$593K |
|
3279
MPLX
MPLX
$60.8B
| $586K | ﹤0.01% |
16,442
+1,538
| +10% | +$53.7K |
|
3280
Telos
TLS
$324M
| $585K | ﹤0.01% |
244,900
+12,100
| +5% | +$27.8K |
|
|
FSR
3281
DELISTED
Fisker Inc.
FSR
| $584K | ﹤0.01% |
91,020
+4,165
| +5% | +$25.3K |
|
3282
ARS Pharmaceuticals
SPRY
$601M
| $584K | ﹤0.01% |
154,511
-121,675
| -44% | -$799K |
|
3283
Fate Therapeutics
FATE
$317M
| $584K | ﹤0.01% |
275,492
+27,394
| +11% | +$90.8K |
|
|
LL
3284
DELISTED
LL Flooring Holdings, Inc.
LL
| $584K | ﹤0.01% |
184,200
+27,500
| +18% | +$99K |
|
3285
Educational Development Corp
EDUC
$11.8M
| $577K | ﹤0.01% |
544,223
-7,123
| -1% | -$10.1K |
|
|
HTD
3286
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$905M
| $576K | ﹤0.01% |
32,408
+2,646
| +9% | +$52K |
|
3287
Sanara MedTech
SMTI
$316M
| $575K | ﹤0.01% |
18,467
-164
| -0.9% | -$6.35K |
|
3288
Universal Insurance Holdings
UVE
$1.18B
| $571K | ﹤0.01% |
40,730
-96,841
| -70% | -$1.36M |
|
3289
Opendoor
OPEN
$3.39B
| $571K | ﹤0.01% |
223,368
-8,466
| -4% | -$30.5K |
|
3290
Cullinan Oncology
CGEM
$1.26B
| $567K | ﹤0.01% |
62,608
-258
| -0.4% | -$2.69K |
|
|
DENN
3291
DELISTED
Denny's
DENN
| $566K | ﹤0.01% |
+66,800
| New | +$676K |
|
3292
XP
XP
$7.98B
| $563K | ﹤0.01% |
24,398
+607
| +3% | +$15.2K |
|
|
GPMT
3293
Granite Point Mortgage Trust
GPMT
$58.8M
| $562K | ﹤0.01% |
114,904
+42,168
| +58% | +$227K |
|
3294
KraneShares Global Carbon Strategy ETF
KRBN
$131M
| $561K | ﹤0.01% |
15,447
-427
| -3% | -$16.1K |
|
3295
Great Southern Bancorp
GSBC
$877M
| $561K | ﹤0.01% |
11,715
-4,280
| -27% | -$223K |
|
3296
Spero Therapeutics
SPRO
$68.9M
| $561K | ﹤0.01% |
463,641
-4,319
| -0.9% | -$5.98K |
|
3297
Greenwich LifeSciences
GLSI
$248M
| $560K | ﹤0.01% |
63,404
-4,788
| -7% | -$45K |
|
3298
First Trust S&P REIT Index Fund
FRI
$202M
| $560K | ﹤0.01% |
24,491
-3,594
| -13% | -$88.1K |
|
3299
Invesco S&P SmallCap Information Technology ETF
PSCT
$516M
| $558K | ﹤0.01% |
12,746
-2,278
| -15% | -$106K |
|
3300
Invesco Municipal Trust
VKQ
$545M
| $557K | ﹤0.01% |
66,744
+4,413
| +7% | +$40.5K |
|
Similar funds
Ameriprise's Q3 2023 Portfolio in Review
As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
- Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
- Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
- Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
- Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
- Ameriprise opened 127 new positions and closed 148 in Q3 2023.
- Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.